develop
antivir
strategi
treat
prevent
noroviru
infect
press
matter
norovirus
number
caus
acut
gastroenter
foodborn
ill
sporad
gastroenter
age
group
sever
acut
gastroenter
children
less
year
old
seek
medic
assist
usacdc
develop
countri
norovirus
link
signific
mortal
children
year
old
norovirus
major
culprit
closur
hospit
ward
associ
increas
hospit
mortal
among
elderli
transplant
patient
signific
risk
acquir
persist
noroviru
gastroenter
control
prevent
strategi
limit
use
disinfect
hand
sanit
whose
efficaci
frequent
insuffici
henc
ampl
need
antivir
treatment
prophylaxi
noroviru
infect
fact
hand
inhibitor
noroviru
replic
report
larg
attribut
hamper
inabl
cultiv
human
norovirus
cell
cultur
norwalk
repliconbear
cell
murin
norovirusinfect
cell
line
avail
model
assess
vitro
antivir
activ
compound
human
norovirus
shown
replic
extent
mice
calv
gnotobiot
pig
chimpanze
infect
interferondefici
mice
murin
noroviru
result
virusinduc
diarrhea
review
recent
develop
understand
noroviru
protein
host
cell
factor
may
serv
target
inhibit
viral
replic
given
recent
advanc
signific
progress
search
antivir
strategi
noroviru
infect
expect
upcom
year
elsevi
inc
right
reserv
day
howev
prolong
sever
diseas
includ
dehydr
diarrhea
occur
vulner
popul
children
elderli
immunocompromis
postinfecti
function
gastrointestin
disord
irrit
bowel
syndrom
report
noroviru
gastroenter
report
sequela
includ
necrot
enterocol
convuls
encephalopathi
detect
noroviru
serum
patient
scarc
report
signific
find
yet
well
understood
immunocompromis
individu
noroviru
gastroenter
becom
chronic
persist
week
year
estim
preval
inde
increas
number
studi
show
immunosuppress
therapi
risk
factor
noroviru
infect
patient
often
present
dramat
weight
loss
due
prolong
norovirusrel
diarrhea
togeth
malnutrit
dehydr
alter
intestin
mucos
barrier
may
contribut
increas
morbid
aggrav
outcom
underli
diseas
transplant
recipi
chronic
noroviru
infect
may
requir
adjust
reduct
immunosuppress
therapi
transmiss
noroviru
occur
via
fecalor
rout
consumpt
contamin
food
water
sourc
food
handler
fomit
recreat
water
via
aerosol
particl
vomitu
stool
main
rout
transmiss
outbreak
persontoperson
thu
favor
occurr
larg
outbreak
semiclos
environ
extens
outbreak
explain
low
infecti
dose
noroviru
viru
particl
suffici
infect
shed
stool
day
also
present
asymptomat
individu
long
persist
environ
resist
disinfect
heat
freez
two
week
surfac
addit
noroviru
infect
occur
repeatedli
life
due
lack
complet
crossprotect
divers
noroviru
strain
lack
longlast
immun
current
treatment
noroviru
infect
mere
support
natur
electrolyt
replenish
dehydr
individu
outbreak
control
prevent
strategi
limit
use
disinfect
hand
sanit
whose
efficaci
enter
pathogen
may
limit
insuffici
henc
ampl
need
specif
antivir
treatment
prophylaxi
noroviru
infect
norovirus
belong
famili
calicivirida
compris
five
genera
noroviru
sapoviru
lagoviru
vesiviru
neboviru
tent
genera
propos
follow
character
simian
tulan
viru
porcin
st
rian
viru
avian
bayern
viru
two
genera
noroviru
sapoviru
compris
human
virus
caus
gastroenter
genera
repres
anim
virus
norovirus
divid
six
genogroup
base
amino
acid
sequenc
divers
major
structur
protein
genogroup
gi
divid
genotyp
gii
genotyp
human
norwalk
viru
prototyp
genu
design
human
pathogen
found
gi
gii
rare
giv
giii
compris
bovin
ovin
strain
gv
murin
norovirus
addit
swine
strain
classifi
gii
canin
strain
giv
gvi
due
close
genet
related
human
anim
norovirus
plu
detect
antibodi
anim
strain
human
human
strain
pig
possibl
zoonot
transmiss
rais
human
norovirus
caus
vast
major
outbreak
novel
variant
emerg
becom
global
predomin
multipl
time
past
decad
cyclic
emerg
novel
strain
displac
previous
predomin
one
caus
worldwid
epidem
suggest
pattern
epoch
evolut
resembl
influenza
norovirus
small
nonenvelop
virus
nm
linear
positivesens
singlestrand
ss
rna
genom
kb
organ
three
open
read
frame
end
encod
polyprotein
sixseven
nonstructur
protein
product
encod
major
minor
structur
capsid
protein
respect
murin
noroviru
mnv
genom
compris
addit
encod
virul
factor
viral
protein
vpg
virion
protein
genomelink
coval
link
end
noroviru
genom
polyadenly
end
noroviru
encod
sixseven
nonstructur
protein
follow
order
protein
ntpase
vpg
viral
proteas
pro
viral
rnadepend
rna
polymeras
rdrp
virion
contain
copi
dimer
major
structur
protein
assembl
icosahedr
particl
protein
divid
conserv
intern
shell
domain
variabl
protrud
domain
p
domain
form
archlik
protrus
subdomain
locat
outmost
surfac
viral
capsid
compris
hypervari
region
resid
bind
interfac
histoblood
group
antigen
hbga
associ
noroviru
small
basic
structur
protein
present
one
two
copi
per
virion
associ
domain
interior
surfac
capsid
like
involv
capsid
assembl
genom
encapsid
noroviru
viruslik
particl
vlp
form
independ
express
selfassembl
morpholog
antigen
indistinguish
nativ
form
virus
found
human
stool
retain
bind
properti
nativ
noroviru
virion
least
term
carbohydr
associ
suscept
noroviru
infect
estim
present
adult
larg
depend
host
genotyp
particularli
presenc
specif
human
hbga
receptor
gut
suscept
host
limit
knowledg
immun
respons
human
noroviru
deriv
volunt
studi
inabl
measur
serum
intestin
secretori
neutral
antibodi
tissu
cultur
made
hard
studi
protect
immun
studi
perform
multipl
noroviru
genotyp
variabl
outcom
like
affect
preexposur
histori
volunt
shortterm
immun
demonstr
like
viru
serotyp
specif
longterm
immun
harder
put
evid
level
intestin
secretori
antibodi
appear
correl
protect
higher
level
serum
antibodi
titer
particularli
natur
infect
noroviru
vlp
p
particl
p
domain
propos
vaccin
candid
clinic
efficaci
studi
norwalk
viru
vlp
administ
intranas
two
dose
three
week
apart
healthi
adult
volunt
show
homotyp
protect
vaccin
reduc
frequenc
norwalk
viru
gastroenter
placebo
recipi
vs
vaccin
recipi
specif
iga
antibodi
detect
high
level
vaccin
recipi
optim
antigen
dose
rout
administr
adjuv
type
noroviru
strain
present
noroviru
vaccin
yet
determin
import
aspect
address
whether
immunogen
protect
efficaci
elderli
popul
young
children
primarili
durat
protect
immun
vaccin
could
becom
major
challeng
given
great
antigen
genet
divers
norovirus
practic
use
vaccin
requir
oneyear
minimum
protect
immun
feasibl
recent
bival
vlp
vaccin
two
dose
intramuscular
inject
carri
wwwclinicaltrialsgov
howev
result
yet
offici
disclos
case
trial
constitut
import
step
feasibl
noroviru
vaccin
convers
need
specif
antivir
therapi
remain
case
chronic
infect
immunocompromis
patient
elderli
children
sever
ongo
infect
prophylact
control
fastgrow
outbreak
vitro
vivo
model
system
anim
virus
within
caliciviru
famili
use
surrog
yet
noncultiv
human
noroviru
includ
porcin
enter
caliciviru
pec
sapoviru
felin
caliciviru
fcv
vesiviru
tulan
viru
tent
recoviru
tabl
virus
use
persist
inactiv
studi
differ
term
genom
organ
rout
infect
pathogenesi
make
far
ideal
human
noroviru
antivir
drug
discoveri
close
relat
murin
noroviru
gv
noroviru
wide
use
date
noroviru
known
replic
cell
line
small
anim
model
tabl
viru
allow
studi
multipl
aspect
noroviru
biolog
present
consid
central
tool
antivir
studi
human
noroviru
genom
mnv
three
orf
characterist
norovirus
encod
nonstructur
protein
orf
encod
structur
protein
howev
addit
overlap
differ
read
frame
encod
protein
involv
host
innat
immun
respons
similar
genom
organ
protein
function
structur
allow
assum
fundament
aspect
mnv
human
noroviru
replic
highli
conserv
furthermor
mnv
replic
mice
spread
fecalor
rout
shed
high
level
fece
thu
enter
viru
capabl
induc
gastroenter
similar
pathogenesi
human
noroviru
murin
noroviru
shown
replic
mice
kupffer
cell
liver
splenic
cell
macrophagelik
morpholog
base
observ
research
carri
studi
replic
noroviru
cell
cultur
monocytemacrophag
origin
vitro
cell
cultur
model
murin
noroviru
reveal
viru
replic
murin
bone
marrow
deriv
macrophag
dendrit
cell
also
differ
macrophag
cell
line
ex
raw
vitro
system
extrem
import
studi
murin
noroviru
life
cycl
despit
extens
effort
vitro
cell
cultur
model
avail
human
noroviru
duizer
et
al
explor
human
anim
cell
line
mainli
deriv
gastrointestin
system
none
support
signific
replic
human
noroviru
other
investig
propag
human
noroviru
threedimension
cultur
intestin
epitheli
cell
also
effort
remain
unsuccess
yield
reproduc
result
laboratori
focus
human
noroviru
replic
cell
cultur
hematopoiet
origin
one
group
investig
whether
macrophag
dendrit
cell
differenti
vitro
human
peripher
blood
mononuclear
cell
sustain
human
noroviru
replic
studi
reveal
low
number
dendrit
cell
infect
norwalk
viru
vitro
cell
per
inocul
cell
insuffici
caus
increas
viral
rna
mention
studi
norwalk
viru
human
noroviru
strain
employ
similar
effort
cultiv
human
noroviru
human
murin
cell
line
hematopoiet
origin
remain
also
unsuccess
howev
studi
infect
product
replic
human
noroviru
ex
vivo
cultur
use
adult
human
duoden
tissu
observ
limit
replic
note
glandular
epitheli
cell
line
lack
cell
cultur
model
human
noroviru
perhap
import
challeng
discoveri
novel
antivir
strategi
fortun
altern
approach
least
studi
noroviru
rna
replic
avail
human
noroviru
repliconbear
cell
line
creat
transfect
plasmid
contain
nearli
complet
norwalk
viru
genom
mammalian
cell
line
system
allow
studi
entri
matur
human
noroviru
use
investig
activ
inhibit
replic
enzym
nonstructur
protein
way
employ
find
inhibitor
viral
protein
cellular
context
addit
system
also
abl
studi
activ
inhibit
host
factor
involv
human
noroviru
replic
small
anim
model
human
noroviru
infect
key
tool
studi
viral
pathogenesi
also
enabl
proof
tabl
diarrhea
observ
chimpanze
intraven
iv
infect
induc
weeklast
shed
stool
serum
antibodi
respons
viru
detect
intestin
liver
biopsi
gnotobiot
pig
calv
howev
diarrhea
mild
lesion
intestin
observ
result
oral
infect
stool
filtrat
contain
noroviru
larg
anim
model
help
shed
light
inhibit
replic
human
pathogen
howev
largescal
studi
hardli
feasibl
addit
anim
model
use
surrog
virus
also
avail
largeanim
model
porcin
sapoviru
pec
cowden
strain
replic
swine
tulan
viru
replic
rhesu
macaqu
also
provid
opportun
studi
clinic
featur
pathogenesi
calicivirus
known
strain
murin
noroviru
replic
mice
major
caus
persist
asymptomat
infect
immunocompet
mice
tabl
howev
mice
lack
compon
innat
immun
signal
transduc
activ
transcript
alphabeta
ifnab
gamma
ifng
interferon
receptor
mnv
caus
either
persist
acut
lethal
infect
infect
strain
innat
immun
defici
mice
develop
sever
diarrhea
weight
loss
mortal
four
nine
day
infect
viral
rna
detect
mice
high
level
intestin
lung
liver
spleen
brain
blood
fece
clinic
symptom
observ
sever
pneumonia
destruct
splenic
liver
tissu
caus
fatal
diseas
case
mortal
model
display
featur
similar
pathogenesi
human
noroviru
infect
human
name
infect
via
oral
rout
diarrhea
gastric
bloat
shed
stool
high
level
two
variant
select
initi
isol
viru
plaqu
purif
passag
cell
cultur
genet
differ
four
amino
acid
equal
virul
parent
strain
immunocompromis
mice
attenu
detect
vivo
sole
h
pi
immunocompet
mice
howev
infect
caus
modest
intestin
patholog
fecal
inconsist
clear
less
one
week
recent
mnv
strain
identifi
amino
acid
chang
genom
strain
link
persist
tropism
caus
mild
symptom
mice
comparison
strain
less
weight
loss
moder
gastric
bloat
fecal
inconsist
clear
one
week
wildtyp
mice
infect
asymptomat
persist
week
month
convers
strain
persist
asymptomat
wildtyp
innat
immunedefici
mice
present
thu
differ
phenotyp
potenti
persist
mnv
strain
may
use
model
studi
noroviru
persist
might
also
becom
use
antivir
studi
given
increas
recognit
prolong
noroviru
infect
immunocompromis
patient
noroviru
virion
recogn
hbga
key
player
initi
viral
attach
act
like
cellular
receptor
coreceptor
noroviru
cell
entri
tabl
hbgabind
interfac
locat
p
domain
viral
capsid
protein
conform
pocket
distal
surfac
viral
capsid
interact
individu
oligosaccharid
residu
hbga
molecul
structur
studi
demonstr
human
noroviru
mainli
perform
use
crystal
xray
diffract
recent
stdnmr
success
use
yield
similar
result
insight
molecular
interact
hbga
human
noroviru
capsid
use
start
point
computerassist
drug
discoveri
approach
million
chemic
structur
screen
silico
potenti
compet
hbga
bind
result
identif
sever
compound
could
block
hbgap
domain
interact
vitro
fig
none
molecul
yet
test
cell
cultur
vivo
model
recent
new
methodolog
use
surfac
plasma
reson
technolog
mass
spectrometri
develop
determin
bind
hbga
viral
capsid
protein
techniqu
prove
also
valuabl
character
bind
oligosaccharid
includ
human
milk
glycan
noroviru
capsid
make
potenti
antiadhes
agent
noroviru
prophylaxi
follow
receptor
bind
virus
take
advantag
cellular
process
enter
cell
mnv
enter
cell
via
clathrin
caveolinindepend
mechan
mediat
dynamin
ii
cholesterol
tabl
insight
mechan
human
noroviru
entri
lack
due
inabl
grow
viru
cell
cultur
observ
simvastatin
lower
cholesterol
level
enhanc
replic
human
noroviru
replicon
vitro
increas
replic
human
noroviru
vivo
highlight
yet
fulli
understood
role
cholesterol
human
noroviru
entri
uncoat
mnv
phindepend
process
surpris
mnv
enter
viru
must
travel
acid
ph
stomach
reach
site
replic
contrast
mani
virus
low
intracellular
ph
trigger
requir
conform
chang
capsid
implic
chemic
frequent
use
prevent
acidif
endosom
inhibit
viru
uncoat
activ
noroviru
genom
norovirus
encod
sixseven
nonstructur
protein
ntermin
protein
ntpase
vpg
viral
proteas
pro
viral
rnadepend
rna
polymeras
rdrp
tabl
nomenclatur
function
protein
predict
base
sequenc
similar
picornaviru
counterpart
noroviru
rdrp
therefor
refer
proteas
ntpase
link
protein
similar
import
stepup
search
antivir
noroviru
picornaviru
counterpart
proven
target
inhibit
viral
replic
mnv
shown
nonstructur
protein
play
role
noroviru
replic
coloc
replic
complex
viral
rna
intermedi
dsrna
mani
rna
virus
replic
complex
mnv
associ
membran
endoplasm
reticulum
er
golgi
apparatu
endosom
intracellular
membran
reorgan
upon
viru
infect
function
yet
well
defin
base
sequenc
similar
thought
compar
picornaviru
protein
particip
intracellular
membran
chang
follow
infect
case
norwalk
viru
infect
seem
interfer
disassembl
golgi
complex
cellular
protein
traffick
studi
mnv
reveal
associ
recruit
er
membran
site
replic
recruit
membran
probabl
vital
format
replic
complex
synthesi
new
viral
protein
recent
ntermin
domain
shown
determin
viru
colon
tropism
persist
exact
mechan
still
unknown
specul
structur
differ
novel
protein
fold
ntermin
domain
influenc
cellular
pathway
viral
infect
result
evas
immun
consequ
viral
persist
given
pleiotrop
function
mechan
control
membran
rearrang
could
good
strategi
stop
noroviru
life
cycl
protein
classifi
protein
superfamili
rna
helicas
share
sequenc
motif
picornaviru
protein
flaviviru
helicasentpas
helicas
enzym
involv
unwind
nucleic
acid
catalyz
hydrolysi
ntp
howev
noroviru
protein
case
picornaviru
protein
ntpase
activ
demonstr
noroviru
helicas
akin
picornaviru
helicas
ring
helicas
unlik
exampl
flaviviru
helicas
attempt
solv
structur
protein
far
unsuccess
sever
molecul
shown
directli
indirectli
interfer
picornaviru
protein
function
block
viral
replic
mechan
action
molecul
still
fulli
character
recent
progress
toward
solv
structur
protein
could
achiev
might
give
insight
mechan
action
inhibitor
gener
opportun
character
noroviru
protein
recent
novel
class
picornaviru
target
compound
discov
molecul
show
potent
broadspectrum
enterorhinoviru
activ
includ
excel
activ
anim
model
enteroviru
infect
function
studi
human
noroviru
shown
protein
affect
golgiphenotyp
antagon
secretori
pathway
mammalian
cell
activ
correl
preserv
endoplasm
reticulum
export
signal
mere
motif
mnv
caus
similar
shift
golgiphenotyp
less
effect
secretori
pathway
picornaviru
protein
noroviru
protein
consid
ortholog
protein
share
locat
viral
genom
interfer
host
secretori
pathway
picornaviru
protein
recruit
silico
struct
biolog
crystallographyxray
surfac
plasma
reson
technolog
mass
spectrometri
std
nmr
matur
viral
protein
substratebas
aldehyd
inhibitor
michaelacceptor
polypeptid
inhibitor
crystallographyxray
biochem
proteas
assay
depend
rna
polymeras
replic
viru
genom
cmethylcytidin
favipiravir
bdn
hydroxycytidin
cell
cultur
model
anim
model
triphosph
triphosph
act
crystallographyxray
rdrp
primertempl
suramin
ppnd
silico
struct
biolog
crystallographyxray
rdrp
absenc
primertempl
biochem
polymeras
assay
iiib
secretori
organel
membran
promot
lipidrich
environ
polymeras
bind
lead
format
replic
complex
variou
molecul
shown
inhibit
therebi
also
viral
replic
interestingli
effect
picornaviru
protein
also
link
reduct
secret
sever
cytokin
regul
tnfreceptor
mhc
class
molecul
cell
surfac
inhibitor
test
noroviru
replic
signific
antivir
activ
found
unpublish
observ
vpg
viral
protein
coval
link
end
rna
genom
picornaand
calicivirus
virus
evolv
proteinprim
mechan
genom
replic
vpg
use
protein
primer
viral
rna
polymeras
addit
vpg
thought
mani
function
recent
review
vpg
probabl
protect
end
rna
detect
cytoplasm
sensor
rigi
pkr
protein
also
interact
directli
capbind
protein
protein
translat
initi
complex
current
hypothesi
hold
vpg
interact
partner
form
hub
assembl
translat
replic
complex
recent
first
highresolut
structur
analysi
nmr
caliciviru
mnv
vpg
protein
report
contrast
vpg
protein
picornavirus
seem
intrins
disord
structur
vpg
protein
mnv
contain
ahel
core
flank
long
unstructur
termini
essenti
tyr
residu
nucleotidyl
viral
polymeras
form
primer
rna
synthesi
locat
first
ahelix
expos
solvent
mnv
vpg
dock
manual
crystal
structur
mnv
rdrp
tyr
residu
could
place
suffici
proxim
activ
site
allow
nucleotidyl
reaction
howev
first
ahelix
detach
vpg
core
thumb
finger
domain
polymeras
move
apart
product
complex
could
form
inhibitor
vpg
function
known
multipl
proteinprotein
interact
may
provid
suitabl
target
antivir
would
import
solv
structur
complex
explor
whether
interact
annihil
specif
inhibitor
recent
picornaviru
vpguridylyl
alphascreen
develop
highthroughput
screen
similar
approach
envis
find
inhibitor
noroviru
vpgguanyl
reaction
atom
structur
norwalk
proteas
first
resolv
high
resolut
cystein
proteas
adopt
chymotrypsinlik
fold
compris
two
domain
similar
viral
cystein
proteas
like
picornaviru
proteas
catalyt
triad
activ
site
consist
cystein
nucleophil
histidin
residu
gener
base
catalyst
glutam
acid
stabil
imidazol
ring
histidin
recent
nmr
also
ad
tool
complement
structur
studi
noroviru
proteas
detail
structur
analysi
noroviru
proteas
natur
substrat
inhibitor
activ
site
perform
prevent
cleavag
natur
substrat
crystal
activ
site
cystein
mutat
alanin
structur
obtain
show
proteas
induc
extend
bstrand
conform
substrat
addit
explain
cleavag
specificitydetermin
interact
conserv
across
viral
serinelik
proteas
compar
analysi
structur
calicivirus
picornavirus
coronaviru
proteas
reveal
glu
gln
posit
make
ident
set
interact
involv
highli
conserv
thr
tyr
residu
pocket
pocket
show
great
flexibl
associ
substrat
bind
chang
correl
alter
pocket
inhibitor
test
irrevers
inhibitor
coval
link
activ
site
cystein
residu
fig
differ
reactiv
group
bisulfit
ester
aldehyd
ketoamid
keton
use
function
assay
detect
proteas
activ
caliciviru
use
fluorogen
substrat
peptid
bioluminesc
technolog
develop
show
biochem
activ
noroviru
proteas
inhibitor
limit
k
mm
molecul
show
broadspectrum
antivir
activ
cell
cultur
ec
mm
variou
member
calici
picornaand
coronaviru
famili
caliciviru
rdrp
sequenc
structur
motif
found
canon
viral
rdrp
differ
nucleosid
analogu
cocrystal
activ
site
mnv
rdrp
fig
surprisingli
primertempl
rna
need
also
need
use
phosphoryl
form
nucleosid
explain
nucleosid
test
ribavirin
bind
flexibl
andor
slightli
shift
expect
conform
relev
approach
find
inhibitor
question
exampl
ribavirin
show
similar
bind
mode
crystal
structur
differ
significantli
potenc
block
mnv
replic
vitro
structur
human
noroviru
rdrp
bound
rna
primertempl
duplex
nucleosidetriphosph
analogu
also
obtain
like
relev
understand
noroviru
polymeras
target
one
studi
bind
mode
natur
substrat
ctp
potent
competit
inhibitor
triphosph
determin
precis
posit
nucleotid
exert
signific
effect
effici
nucleotidyl
transfer
reaction
suggest
seri
hydrogenbond
van
der
waal
interact
ribos
moieti
may
play
import
role
nucleotid
recognit
posit
within
activ
site
second
studi
bind
triphosph
investig
bind
mode
nucleotid
activ
site
forc
enzym
remain
open
inact
conform
regard
novel
mechan
inhibit
structur
chang
attribut
replac
hydroxyl
group
amino
group
rearrang
polymeras
activ
site
disrupt
coordin
shell
activesit
metal
ion
replac
hydroxyl
group
therefor
suggest
gener
approach
design
rdrp
inhibitor
recent
cocryst
interact
nonnucleotid
inhibitor
human
noroviru
rdrp
absenc
rna
primertempl
duplex
solv
interestingli
studi
start
crystal
structur
human
noroviru
rdrp
bound
rna
primertempl
duplex
ctp
remov
ctp
short
dsrna
base
structur
author
screen
small
set
molecul
potenti
bind
activ
site
silico
two
interest
compound
show
clear
inhibit
human
noroviru
polymeras
vitro
crystal
xray
diffract
experi
togeth
mutat
analysi
subsequ
demonstr
absenc
substrat
molecul
bind
activ
site
mnv
human
noroviru
polymeras
addit
followup
studi
use
revers
fragment
screen
unravel
novel
bind
site
third
inhibitor
rdrp
thumb
domain
virus
requir
interact
cellular
machineri
facilit
replic
inhibit
host
cell
factor
essenti
viral
replic
potenti
good
antivir
strategi
particularli
may
less
prone
drug
resist
conserv
secondari
structur
noroviru
genom
found
critic
replic
mnv
infect
region
genom
subgenom
rna
noroviru
interact
host
factor
polypyrimidin
tractbind
protein
ptb
protein
la
precis
function
noroviru
life
cycl
yet
elucid
inhibitor
host
factor
could
potenti
good
antivir
target
help
unravel
detail
noroviru
life
cycl
cellular
pathway
cholesterol
carbohydr
biosynthesi
found
alter
norwalk
repliconbear
cell
dna
microarray
analysi
hepat
c
viru
hcv
replic
cholesterol
biosynthesi
upregul
cholesterollow
statin
act
antivir
blockag
protein
geranylgeranyl
opposit
report
noroviru
statin
simvastatin
increas
replic
norwalk
viru
correl
increas
express
low
densiti
lipoprotein
receptor
ldlr
postul
ldlr
could
play
import
direct
role
viru
replic
particip
viral
replic
complex
essenti
cofactor
addit
bile
acid
cholesterol
biosynthesi
precursor
found
essenti
vitro
replic
peccowden
sapoviru
gnotobiot
pig
simvastatin
increas
infect
human
noroviru
link
suppress
effect
innat
immun
respons
via
interferona
use
statin
inde
regard
risk
factor
sever
noroviru
gastroenter
activ
acylcoa
cholesterol
acyltransferas
acat
also
import
factor
cholesterol
biosynthesi
unlik
statin
treatment
acat
inhibitor
result
reduc
level
norwalk
replic
ldlr
indic
acat
could
target
inhibit
noroviru
replic
noroviru
current
import
pathogen
howev
vaccin
antivir
avail
prevent
treat
noroviru
infect
review
progress
made
develop
differ
tool
facilit
antinoroviru
research
mani
human
noroviru
protein
studi
function
structur
presenc
smallmolecul
inhibitor
first
small
anim
model
human
noroviru
report
model
acut
persist
mnv
infect
report
howev
lack
conveni
vitro
cell
cultur
system
remain
main
hurdl
studi
human
noroviru
replic
inhibit
virus
proven
critic
discoveri
optim
small
molecul
antivir
